• 2012

Company Description

Lewis and Clark Pharmaceuticals is focused on developing drugs for arthritis, diabetes, glaucoma, and atherosclerosis.

Lewis & Clark Pharmaceuticals Subsidiary, Inc. focuses on early stage pharmaceutical development for addressing the areas of arthritis, diabetes, glaucoma, and atherosclerosis. The company was incorporated in 2012 and is based in Charlottesville, Virginia.